← Back to all posts
Late-life semaglutide treatment slows ageing and extends lifespan in female mice
🌟

Late-life semaglutide treatment slows ageing and extends lifespan in female mice

So, researchers have found that treating older female mice with semaglutide, a GLP-1 receptor agonist, can actually slow down the ageing process and extend their lifespan. This is exciting because it suggests that this treatment could mimic the benefits of calorie restriction without the need for strict dieting. The semaglutide-treated mice lived significantly longer than those who didn't receive the treatment, showing a median lifespan increase. It's fascinating to think about how this could translate to potential health benefits for humans as well!
Read the original article ↗
Share